Near-Cure of Gadolinium Deposition Disease with iv DTPA peer-reviewed paper
This is the important paper on treatment. This is the only peer-reviewed article that describes the successful treatment of Gadolinium Deposition Disease (GDD) with any treatment. This means that the only peer-reviewed accepted treatment for GDD is with iv DTPA. All other treatments are unproven, hence not recommended.
There is an ICD10 code for Gadolinium toxicity T56.82. CPT code for treatment (other heavy metals) 83018.
It should be emphasized that we only looked at patients who were in close contact with Dr Semelka and who he had chelated. Since many patients start chelation at my clinic, and I encourage them to continue care closer to home to keep treatment affordable, relatively few patients receive all or most of their care at my facility. I comment on that in the Discussion. Therefore we cannot say what percent go on to near-Cure. My impression is that the great majority, > 90 % could go on to near-cure, but in a number this may require > 50 chelations, when they either have GDD with many complications or multiple GBCA injections, > 10.. This is prohibitively expensive for the great majority of patients. Also I want to emphasize that perseverance is critical, the path to near cure with chelation includes rocks and shoals along the stream, and those that succeed understand this and bear through it. There are often unexpected bumps in Flare severity, but these can be overcome by continuing chelation.
Here is the paper:
Congratulations on the publication of your article: Near-Cure in Patients with Gadolinium Deposition Disease Undergoing Intravenous DTPA Chelation, by Miguel Ramalho, Richard Semelka, published in Frontiers in Toxicology.
To view the online publication, please click here:
Richard Semelka, MD
Commentaires